Cargando…

Private profits versus public policy : the pharmaceutical industry and the Canadian state /

"The widespread condemnation of drastic price increases on life-saving drugs highlights our growing dependency on and vulnerability to international pharmaceutical conglomerates. However, aren't the interests of the public supposed to supersede the pursuit of private profit? In his new wor...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Lexchin, Joel, 1948- (Autor)
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Toronto ; Buffalo ; London : University of Toronto Press, [2016]
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000Ii 4500
001 JSTOR_ocn959713789
003 OCoLC
005 20231005004200.0
006 m o d
007 cr cnu---unuuu
008 161003s2016 onc ob 001 0 eng d
040 |a N$T  |b eng  |e rda  |e pn  |c N$T  |d N$T  |d EBLCP  |d YDX  |d CELBN  |d IDB  |d ZCU  |d OTZ  |d UAB  |d TEFOD  |d TOH  |d OCLCQ  |d IGB  |d MERUC  |d D6H  |d CAUOI  |d CN8ML  |d OCLCF  |d VTS  |d CEF  |d RRP  |d OCLCA  |d OCLCQ  |d TKN  |d STF  |d CNTRU  |d M8D  |d UKAHL  |d OCLCQ  |d K6U  |d UNBCA  |d OCLCO  |d JSTOR  |d OCLCO  |d P@U  |d OCLCQ  |d OCLCO 
019 |a 960448168  |a 960718780 
020 |a 9781442619609  |q (electronic bk.) 
020 |a 1442619600  |q (electronic bk.) 
020 |a 9781442619616  |q (electronic bk.) 
020 |a 1442619619  |q (electronic bk.) 
020 |z 9781442649170 
020 |z 1442649178 
020 |z 9781442626591 
020 |z 1442626593 
029 1 |a AU@  |b 000059028703 
035 |a (OCoLC)959713789  |z (OCoLC)960448168  |z (OCoLC)960718780 
037 |a 3D0F60C5-943C-4733-861D-0AE91686BD89  |b OverDrive, Inc.  |n http://www.overdrive.com 
037 |a 22573/ctv2fhcc4c  |b JSTOR 
043 |a n-cn--- 
050 4 |a HD9670.C22 
055 8 |a HD9670.C22  |b L48546 2016 
072 7 |a BUS  |x 070000  |2 bisacsh 
072 7 |a HEA  |x 028000  |2 bisacsh 
072 7 |a POL  |x 019000  |2 bisacsh 
072 7 |a POL  |x 017000  |2 bisacsh 
072 7 |a MED  |x 102000  |2 bisacsh 
072 7 |a MED  |x 000000  |2 bisacsh 
082 0 4 |a 338.4/761510971  |2 23 
049 |a UAMI 
100 1 |a Lexchin, Joel,  |d 1948-  |e author. 
245 1 0 |a Private profits versus public policy :  |b the pharmaceutical industry and the Canadian state /  |c Joel Lexchin. 
264 1 |a Toronto ;  |a Buffalo ;  |a London :  |b University of Toronto Press,  |c [2016] 
264 4 |c ©2016 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references and index. 
520 |a "The widespread condemnation of drastic price increases on life-saving drugs highlights our growing dependency on and vulnerability to international pharmaceutical conglomerates. However, aren't the interests of the public supposed to supersede the pursuit of private profit? In his new work, Private Profits versus Public Policy, Joel Lexchin addresses this question as he examines how public policy with respect to the pharmaceutical industry has evolved in Canada over the past half century. Although the Canadian government is supposed to regulate the industry to serve the needs of public health, waves of deregulatory reforms and intellectual property rights legislation have shifted the balance of power in favour of these companies' quest for profit. Joel Lexchin offers a series of recommendations to tip the scale back in the public's favour. This enlightening work is the first book that deals exclusively with the pharmaceutical industry in Canada in over thirty years."--  |c Provided by publisher. 
588 0 |a Online resource; title from PDF title page (EBSCO, viewed October 3, 2016). 
505 0 |a Introduction : why do we care about the pharmaceutical industry in Canada? -- (De)regulation through cooperation -- Biased testing, hidden results, and the regulation of clinical trials -- Approving new drugs : better or just more? -- Regulating promotion or licensing deception? -- Health Canada and drug safety : how safe are we? -- Is intellectual property a right? -- How revenue is generated : prices, volume, mix, and overall spending -- Who gets the value from research and development? -- Canada, the pharmaceutical industry, and access to medicines in the global south -- Courage, my friends; 'tis not too late to build a better world. 
590 |a JSTOR  |b Books at JSTOR Evidence Based Acquisitions 
590 |a JSTOR  |b Books at JSTOR Demand Driven Acquisitions (DDA) 
590 |a JSTOR  |b Books at JSTOR All Purchased 
650 0 |a Pharmaceutical industry  |x Government policy  |z Canada. 
650 0 |a Drug development  |x Government policy  |z Canada. 
650 0 |a Prescription pricing  |x Government policy  |z Canada. 
650 0 |a Profit  |x Government policy  |z Canada. 
650 6 |a Industrie pharmaceutique  |x Politique gouvernementale  |z Canada. 
650 6 |a Médicaments  |x Développement  |x Politique gouvernementale  |z Canada. 
650 6 |a Médicaments  |x Prix  |x Politique gouvernementale  |z Canada. 
650 6 |a Profit  |x Politique gouvernementale  |z Canada. 
650 7 |a BUSINESS & ECONOMICS  |x Industries  |x General.  |2 bisacsh 
650 7 |a HEALTH & FITNESS / Health Care Issues  |2 bisacsh 
650 7 |a Pharmaceutical industry  |x Government policy  |2 fast 
650 7 |a Prescription pricing  |x Government policy  |2 fast 
650 7 |a Profit  |x Government policy  |2 fast 
651 7 |a Canada  |2 fast 
776 0 8 |i Print version:  |z 9781442649170  |z 1442649178 
856 4 0 |u https://jstor.uam.elogim.com/stable/10.3138/j.ctv2fjwxv3  |z Texto completo 
938 |a Project MUSE  |b MUSE  |n musev2_106646 
938 |a Askews and Holts Library Services  |b ASKH  |n AH35087524 
938 |a Askews and Holts Library Services  |b ASKH  |n AH35087523 
938 |a Canadian Electronic Library  |b CELB  |n 451935 
938 |a EBL - Ebook Library  |b EBLB  |n EBL4699940 
938 |a EBSCOhost  |b EBSC  |n 1362452 
938 |a YBP Library Services  |b YANK  |n 13199291 
994 |a 92  |b IZTAP